Home
>
National Drug Code (NDC)
>
Dibenzyline
Dibenzyline - 65197-001-01 - (Phenoxybenzamine Hydrochloride)
Drug Information of Dibenzyline
| Product NDC: | 65197-001 |
| Proprietary Name: | Dibenzyline |
| Non Proprietary Name: | Phenoxybenzamine Hydrochloride |
| Active Ingredient(s): | 10 mg/1 & nbsp; Phenoxybenzamine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Dibenzyline
| Product NDC: | 65197-001 |
| Labeler Name: | WellSpring Pharmaceutical Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA008708 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19991001 |
Package Information of Dibenzyline
| Package NDC: | 65197-001-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (65197-001-01) |
NDC Information of Dibenzyline
| NDC Code | 65197-001-01 |
| Proprietary Name | Dibenzyline |
| Package Description | 100 CAPSULE in 1 BOTTLE (65197-001-01) |
| Product NDC | 65197-001 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Phenoxybenzamine Hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19991001 |
| Marketing Category Name | NDA |
| Labeler Name | WellSpring Pharmaceutical Corporation |
| Substance Name | PHENOXYBENZAMINE HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
